The immune system’s T cell variety drops faster after about age 50

T cell receptor diversity declined faster after about age 50 in an analysis of 1.32 billion T cell clones from 798 people with cancer and 5052 without, published in November 2026 in Aging Cell, and higher diversity was linked to better cancer survival. It is a candidate marker of the immune system’s biological age.

T cells are immune cells that recognize infections and cancer. Each carries a receptor, called a TCR, that recognizes a specific target, so a wide variety of receptors means the body can recognize many threats. That variety, or diversity, is known to shrink with age.

What did the study do?

Researchers combined T cell receptor sequencing data covering 1.32 billion unique T cell clones from 14 independent cohorts: 798 people with cancer and 5052 without cancer. They studied how age, sex and chronic cytomegalovirus (CMV) infection, a common lifelong virus that often causes no symptoms, shape the diversity of receptors in the blood.

What did the study find about biological age?

• T cell receptor diversity declined along a nonlinear path, with loss accelerating after midlife, beyond approximately 50 years of age.
• The rate of decline was further shaped by sex and by CMV infection.
• In people with cancer, higher T cell receptor diversity in the blood was linked to better overall survival across several cancer types, even after accounting for age, sex and CMV.

Why does this matter?

The findings support T cell receptor diversity as a dynamic marker of immune aging. It could one day help estimate how “old” someone’s immune system is, and who may respond better to cancer treatments, including immunotherapy.

How solid is this evidence?

It’s moderate. Mongevity rates it C on our A-to-E scale: a very large data set pooled from many cohorts, but mostly cross-sectional, with links rather than proof of cause. Methods and populations differed between cohorts, and this isn’t yet a test available for routine use.

What are the open questions?

Researchers need to learn whether anything, such as exercise, vaccines or treating CMV, can slow the loss of T cell diversity, and whether measuring it can guide care.

What does this mean for you?

There’s no test to order yet. What helps the immune system age well is familiar: staying active, sleeping well, not smoking, eating a varied diet, keeping vaccines up to date and managing chronic conditions.

How do I explain this at dinner?

Our immune system keeps a library of T cells, each able to spot a different threat. That library shrinks with age, and faster after about 50. People with cancer who still had a bigger library tended to survive longer. A good question for the table: how do you keep your defenses in shape?

In one sentence: T cell receptor diversity declines faster after about age 50, shaped by sex and CMV, and higher diversity was linked to better cancer survival.